A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia.
about
Vasodilators for treating intrauterine growth restrictionDrugs for treatment of very high blood pressure during pregnancyDrugs for treatment of very high blood pressure during pregnancyNitric oxide for preventing pre-eclampsia and its complicationsTreatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold?New approaches for managing preeclampsia: clues from clinical and basic researchOutcome reporting across randomised controlled trials evaluating therapeutic interventions for pre-eclampsia: a systematic review.STRIDER: Sildenafil Therapy In Dismal prognosis Early-onset intrauterine growth Restriction--a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysisEffects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy.The nitric oxide pathway and possible therapeutic options in pre-eclampsiaSildenafil citrate in fetal growth restriction.Sildenafil Inhibits Advanced Glycation End Products-induced sFlt-1 Release Through Upregulation of Heme Oxygenase-1.Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor.From Pre-Clinical Studies to Clinical Trials: Generation of Novel Therapies for Pregnancy Complications.Effect of L-arginine and sildenafil citrate on intrauterine growth restriction fetuses: a meta-analysisEmerging drugs for preeclampsia--the endothelium as a targetReducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double-blind randomised control trial.Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.Sildenafil citrate and uteroplacental perfusion in fetal growth restriction.Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia.Mechanisms and potential therapies for preeclampsiaSildenafil attenuates placental ischemia-induced hypertension.Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia.Early onset fetal growth restriction.Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors.Antiangiogenic-induced hypertension: the molecular basis of signaling network.Future therapies for pre-eclampsia: beyond treading water.Potential targets for the treatment of preeclampsia.Inventory of Novel Animal Models Addressing Etiology of Preeclampsia in the Development of New Therapeutic/Intervention Opportunities.Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.New Models of Pregnancy-Associated Hypertension.Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy.Sildenafil for the treatment of preeclampsia.Sildenafil citrate therapy for severe early-onset intrauterine growth restriction.Endothelial dysfunction in the human umbilical artery due to preeclampsia can be prevented by sildenafil.Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A(165) in the uterine arteries of pregnant sheep.Drug development in preeclampsia: a 'no go' area?STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials.Phosphodiesterase type 5 and cancers: progress and challenges.
P2860
Q24188106-6F7B92A1-C509-4B0F-B02C-BD23EFB217C8Q24200974-43A0A126-6A38-4D3F-BBBE-D716C72D0171Q24244908-A54AED8A-DF8C-4FDE-AF86-6CA13CDD0632Q24245090-0F1CA9AA-0EF8-40A4-BED9-41175AEBAB9AQ26998662-FB19B716-9660-4A68-A1E2-5C416FF43105Q27010670-EBC4A233-2B47-4732-A102-54F5441B87D0Q30234715-E3F7D456-927B-4449-A344-5AFEE989CE03Q30775123-837F843C-AE22-4E48-9F1D-9BFB984E0322Q33686622-A9BFBCA9-9587-4229-90E4-419B8FDC0C8DQ34065261-3A2D6A13-45F9-47A2-A417-CA6F4EF4315FQ34067739-A83A3B93-5926-431E-AB23-8EF9BB0253F1Q34391174-3E3CF0ED-245E-4F25-B8BB-3F3BF98957A7Q35570951-29CFC2CE-A28D-44D4-9B48-559ADA69B020Q35813932-F6A70438-B0E1-4986-95A4-8F08ECA85506Q36104605-37CDBC8E-273C-427C-B735-DECFC8767767Q36420578-A3ABB1C5-A27F-49BF-82ED-CD4CC87DF22FQ36461709-0E722E21-4367-4940-ACEC-3768925CE758Q36576619-E92B8CBA-6B6D-425D-B297-952D274B94E4Q36901534-4520F678-4E17-4DF8-A261-F27D7DC8F78DQ36938086-CD227780-ED60-4626-9D4F-52D03384A639Q37042332-55A299E7-6CEE-4E20-A3F6-FBA233203D43Q37211008-10A2D211-748B-463A-A071-F2547092E552Q37323529-28FC98AA-BD15-432F-A1B1-98B49C0FB007Q37497663-0ADD325B-A96B-428D-A61E-64A7FD98370EQ37591488-339D0CA2-DAF5-4CC2-A0EC-85FA32CDD05CQ37903037-0BD827AA-A615-4CF0-B747-282D468D3502Q37973600-B2C83852-3BFC-4076-BBB8-18B6ADB4BFA6Q38151169-98C6983D-7558-4040-ADD7-20953B69A4AFQ38590180-50548395-0332-4B44-8B46-C8924404BFEAQ38674096-1286C6AB-1F35-4657-92D7-83D0109CA4E3Q39208841-54943AF0-2618-4D18-BCDE-8B7D4EDA1183Q39283914-0C336BB1-09F3-41B6-BC23-8A6DCA1A1F5BQ39898235-15CE8963-30CA-4560-9548-F2A421B33D71Q43109528-F490EA8A-1140-4495-9ADD-A5657283A316Q43639662-B2FA9146-767C-4327-B641-BECDC4E3315AQ44308542-CD48D2AB-554F-446C-A586-5CCCDED96E80Q45874209-6A9CA039-74FE-4D79-A181-5424266EAD3FQ46328251-FBD6B322-DD6C-403A-A835-6244FEF9E4A6Q47141250-B12706AF-8000-4105-8D98-C0290124D422Q47171803-1DD87138-ECDF-4C02-864F-087C67A66D33
P2860
A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
A randomised, double-blinded, ...... the treatment of preeclampsia.
@en
A randomised, double-blinded, ...... the treatment of preeclampsia.
@nl
type
label
A randomised, double-blinded, ...... the treatment of preeclampsia.
@en
A randomised, double-blinded, ...... the treatment of preeclampsia.
@nl
prefLabel
A randomised, double-blinded, ...... the treatment of preeclampsia.
@en
A randomised, double-blinded, ...... the treatment of preeclampsia.
@nl
P2093
P2860
P921
P1476
A randomised, double-blinded, ...... the treatment of preeclampsia.
@en
P2093
Alison McLeod
Andrew Shennan
David Howe
Gary Mires
Laurence Skillern
Rebekah A Samangaya
P2860
P304
P356
10.3109/10641950802601278
P577
2009-08-01T00:00:00Z